The quality-adjusted life year (QALY) metric took center stage during a recent panel at the International Society for Pharmacoeconomics and Outcomes (ISPOR) 2019 meeting in New Orleans, Louisiana. Panelists during the discussion, "The Controversial QALY: Is There a Middle Ground in the Debate?", […]
Accelerated Expansion of MEDiSTRAVA With Acquisition of Creativ-Ceuticals
Press Release Huntsworth plc on Tuesday, May 21, announced the acquisition of Creativ-Ceuticals (CC), global pioneers in health economics and market access. With the acquisition of CC, MEDiSTRAVA (the dedicated medical division of Huntsworth) provides powerful strategic and technical capability […]
BHE Receives $78 Million in Growth Funding from Silversmith, LTP
BHE received a $78 million minority growth investment led by Silversmith Capital Partners (Silversmith) and Leerink Transformation Partners (LTP), the company announced last week. According to a press release, the funding will go toward bolstering BHE's Instant Health Data (IHD) platform, a […]
Xcenda Acquires Dymaxium to Bolster Payer-Manufacturer Communications
Xcenda on Tuesday, May 21, announced the acquisition of Dymaxium as it looks to streamline the exchange of value information between drug manufacturers and payers. As part of the deal, Xcenda will acquire Dymaxium's FormularyDecisions.com platform which was launched to provide payers "efficient […]
Frakt: Is U.S. Health Spending Worth It?
In a recent article published on the New York Times, Austin Frakt, director of the Partnered Evidence-Based Policy Resource Center at the V.A. Boston Healthcare System, writes that while U.S. health care spending is the most expensive, "health care is still a bargain." "Consider this analogy: If […]
AESARA’s Pham, Okamoto Outline Mission, Method
HealthEconomics.Com Founder and CEO Dr. Patti Peeples recently interviewed AESARA's Sissi Pham, CEO, and Lynn Okamoto, chief business and technology officer, about how the digital-forward market access agency is carving out its own unique path. Pham launched AESARA in 2016 with the goal of […]
HealthEconomics.Com Needs Your Help!
Don't miss out on your opportunity to receive HealthEconomics.Com's executive summary on the pay and benefits received by your peers in health economics and outcomes research, real-world evidence and market access! HealthEconomics.Com is in the midst of its 3rd Bi-Annual 2019 HEOR, RWE and Market […]
ICER Announces New Cloud-Based Tools
The Institute for Clinical and Economics Review (ICER) announced Monday, May 20, that it is developing two new tools aimed at streamlining stakeholders' ability to examine the organization's "entire body of work" to bolster decision-making. ICER made the announcement during the International […]
ICER Says J&J’s Spravato is Overpriced
Johnson & Johnson's new therapy to treat resistant depression, Spravato, is overpriced, according to the Institute for Clinical and Economic Review (ICER), though it could provide a "comparable, small, or substantial net health benefit" for patients. According to a FiercePharma report, the […]
AMCP Foundation Opens Memorial Fund for Carroll
The Academy of Managed Care Pharmacy (AMCP) Foundation recently announced a memorial fund to honor the late Cathy Carroll, funds from which will support future pharmacists. Carroll started her 35-plus year career in her home state, Missouri, and later worked her way to become "an international […]
